Skip to main content

This job has expired

You will need to login before you can apply for a job.

Quality Control Manager

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Dec 31, 2020

View more

Discipline
Quality, Quality Control
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Genetown

Job Details

Our Mission: Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Job Description:

R eporting to the Associate Director of Quality Control, the Quality Control Manager will oversee Quality Control activities in support of GMP manufacturing programs. The individual will manage a team to support externally sourced projects, internal testing, quality events, and documentation related to the assigned contract organizations. The individual will act as interdepartmental liaison to various groups, including Analytical Development, Manufacturing Quality Assurance, and Regulatory Affairs.

Responsibilities:

  • Manage product testing activities at contact manufacturing organizations/labs
  • Coach and mentor staff in all aspects of their job performance and career development
  • Manage routine activities conducted by the Quality Control function
  • Develop/maintain departmental reference standard program, QC processes and procedures
  • Drive Change Controls, Deviations, and CAPAs from initiation to completion
  • Represent Quality Control on cross-functional project teams
  • Support GMP audits of contract testing sites
  • Author/review relevant sections of regulatory submission documents
  • Assist with development and maintenance of departmental budget


Qualifications:
  • Bachelor's degree in a scientific field with a minimum of 8+ years of experience in a GMP laboratory, with a minimum of 5+ years of team leadership experience
  • Knowledge with the use and interpretation of guidance's including ICH, USP/NF, EP
  • Knowledge and experience of computer software packages ( e.g ., LIMS, EDMS, etc).
  • Strong technical understanding of complex analytical techniques, including HPLC/UPLC, CE, MS, UV, and gel electrophoresis
  • Experience with electronic Quality systems ( e.g. LIMS, EDMS)
  • Experience managing contract laboratories, preferred
  • Knowledge of microbiological techniques, preferred
  • Knowledge of analytical techniques associated with gene therapy products, preferred
  • Travel Requirements 0-10%


EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert